Fil LTD Verona Pharma PLC Transaction History
Fil LTD
- $116 Billion
- Q3 2025
A detailed history of Fil LTD transactions in Verona Pharma PLC stock. As of the latest transaction made, Fil LTD holds 3,488,500 shares of VRNA stock, worth $373 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
3,488,500Holding current value
$373 Million% of portfolio
0.32%Shares
3 transactions
Others Institutions Holding VRNA
# of Institutions
293Shares Held
84.9MCall Options Held
984KPut Options Held
3.11M-
Janus Henderson Group PLC London, X06.13MShares$656 Million0.3% of portfolio
-
Perceptive Advisors LLC New York, NY5.51MShares$589 Million22.87% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y94.13MShares$441 Million16.48% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$362 Million16.88% of portfolio
-
Glazer Capital, LLC New York, NY3.21MShares$343 Million11.48% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.52B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...